CG
STTK icon

Cutler Group’s Shattuck Labs STTK Stock Holding History

Cutler Group’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$26K Buy
+3,000
New +$27.5K 0.01% 925

Other funds holding STTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cutler Group's STTK Position: Q1 2024 in Review

Cutler Group opened a new position in Shattuck Labs (STTK) in Q1 2024: 3,000 shares worth $26K. The stake represents 0.01% of the portfolio and ranks #925 among its holdings.

69 funds tracked by Wall St. Rank hold STTK as of Q1 2024.

  • Cutler Group held 3,000 shares of Shattuck Labs worth $26K as of Q1 2024.
  • Shattuck Labs was a new Cutler Group position in Q1 2024.
  • Shattuck Labs made up 0.01% of Cutler Group's portfolio in Q1 2024, its #925 holding.
  • 69 funds tracked by Wall St. Rank held Shattuck Labs as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.